Xiaobo Wang, Mark R. Sommerfeld, Kerstin Jahn‐Hofmann, Bishuang Cai, Aveline Filliol, Helen E. Remotti, Robert F. Schwabe, Aimo Kannt, Ira Tabas – 23 July 2019 – Nonalcoholic steatohepatitis (NASH) is emerging as a major public health issue and is associated with significant liver‐related morbidity and mortality. At present, there are no approved drug therapies for NASH.
23 July 2019
Michelle A. Camarata, Aftab Ala, Michael L. Schilsky – 23 July 2019 – We evaluate Wilson disease (WD) treatment with zinc acetate (U.S. Food and Drug Administration approved) and alternative zinc salts. Studies examining zinc therapy in WD are few, and data on alternative zinc salts are limited. We describe one of the largest recent studies of zinc therapy in WD.
23 July 2019
23 July 2019
23 July 2019
Jose Castellote, José Maria Mora Luján, Antoni Riera‐Mestre – 22 July 2019
Narendra S. Choudhary, Sanjiv Saigal, Arvinder S. Soin – 22 July 2019
Guido Carpino, Lorenzo Nevi, Diletta Overi, Vincenzo Cardinale, Wei‐Yu Lu, Sabina Di Matteo, Samira Safarikia, Pasquale Bartolomeo Berloco, Rosanna Venere, Paolo Onori, Antonio Franchitto, Stuart J. Forbes, Domenico Alvaro, Eugenio Gaudio – 22 July 2019